{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_339"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_339","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"A mutation in the gene PTPN22 as an indicator of risk for idiopathic thrombocytopenic purpura","abstract":"A MUTATION IN THE GENE PTPN22 AS AN INDICATOROF RISK IN IDIOPATHIC THROMBOCYTOPENIC PURPURAByMatthew B. ZamoraImmune-mediated thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet count and antibody mediated platelet destruction. ITP may be due to a failure of T-cell tolerance. Protein tyrosine phosphatase non receptor type 22 (PTPN22) is an important negative regulator of signal transduction from the T cell receptor. A single nucleotide polymorphism 1858C>T in the PTPN22 gene has been associated with various autoimmune disorders with an autoantibody component. We hypothesize that the PTPN22 mutation 1858C>T would be present in a higher proportion of ITP patients due to the humoral immunological component of the disease. We genotyped 45 patients with ITP by a Polymerase Chain Reaction (PCR) based restriction length polymorphism(RFLP) to identify the mutation 1858C>T in the gene PTPN22. Ten patients (22.2%) were heterozygous for the PTPN22 mutation and 2 were homozygous for the mutation (4.4%). The allele frequency of T allele in this ITP group is 15.5%. This compares with a T allele frequency of 8.6% observed in a published population study of 926 controls. Our results indicate that PTPN22 mutation allele is increased in ITP patients when compared to this control group with a P value of 0.02.","abstract_html":"A MUTATION IN THE GENE PTPN22 AS AN INDICATOROF RISK IN IDIOPATHIC THROMBOCYTOPENIC PURPURAByMatthew B. ZamoraImmune-mediated thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet count and antibody mediated platelet destruction. ITP may be due to a failure of T-cell tolerance. Protein tyrosine phosphatase non receptor type 22 (PTPN22) is an important negative regulator of signal transduction from the T cell receptor. A single nucleotide polymorphism 1858C&gt;T in the PTPN22 gene has been associated with various autoimmune disorders with an autoantibody component. We hypothesize that the PTPN22 mutation 1858C&gt;T would be present in a higher proportion of ITP patients due to the humoral immunological component of the disease. We genotyped 45 patients with ITP by a Polymerase Chain Reaction (PCR) based restriction length polymorphism(RFLP) to identify the mutation 1858C&gt;T in the gene PTPN22. Ten patients (22.2%) were heterozygous for the PTPN22 mutation and 2 were homozygous for the mutation (4.4%). The allele frequency of T allele in this ITP group is 15.5%. This compares with a T allele frequency of 8.6% observed in a published population study of 926 controls. Our results indicate that PTPN22 mutation allele is increased in ITP patients when compared to this control group with a P value of 0.02.","abstract_has_math":false,"creators":["Zamora, Matthew B."],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Gerlach, John A.","Schwartz, Kenneth","Estry, Douglas"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010","date_published":"2010","updated_at":"2026-11-18T18:06:03Z","subjects":["Autoimmune diseases","T cells--Receptors","Immunopathology","Protein-tyrosine phosphatase"],"languages":["English"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:339","isbn:9781124382517","isbn:1124382518","oclc:931832015","umi:1483626","local:Zamora_grad.msu_0128N_10124"],"render_values":[{"text":"etd:339","href":null,"code":true},{"text":"isbn:9781124382517","href":null,"code":true},{"text":"isbn:1124382518","href":null,"code":true},{"text":"oclc:931832015","href":null,"code":true},{"text":"umi:1483626","href":null,"code":true},{"text":"local:Zamora_grad.msu_0128N_10124","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/4mwh-8177","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/4mwh-8177","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_339","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Gerlach, John A.","Schwartz, Kenneth","Estry, Douglas"]},{"key":"dc:creator","label":"Author","values":["Zamora, Matthew B."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2010"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["Text","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Autoimmune diseases","T cells--Receptors","Immunopathology","Protein-tyrosine phosphatase"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:339","isbn:9781124382517","isbn:1124382518","oclc:931832015","umi:1483626","local:Zamora_grad.msu_0128N_10124","https://doi.org/doi:10.25335/4mwh-8177"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["A MUTATION IN THE GENE PTPN22 AS AN INDICATOROF RISK IN IDIOPATHIC THROMBOCYTOPENIC PURPURAByMatthew B. ZamoraImmune-mediated thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet count and antibody mediated platelet destruction. ITP may be due to a failure of T-cell tolerance. Protein tyrosine phosphatase non receptor type 22 (PTPN22) is an important negative regulator of signal transduction from the T cell receptor. A single nucleotide polymorphism 1858C>T in the PTPN22 gene has been associated with various autoimmune disorders with an autoantibody component. We hypothesize that the PTPN22 mutation 1858C>T would be present in a higher proportion of ITP patients due to the humoral immunological component of the disease. We genotyped 45 patients with ITP by a Polymerase Chain Reaction (PCR) based restriction length polymorphism(RFLP) to identify the mutation 1858C>T in the gene PTPN22. Ten patients (22.2%) were heterozygous for the PTPN22 mutation and 2 were homozygous for the mutation (4.4%). The allele frequency of T allele in this ITP group is 15.5%. This compares with a T allele frequency of 8.6% observed in a published population study of 926 controls. Our results indicate that PTPN22 mutation allele is increased in ITP patients when compared to this control group with a P value of 0.02.","Thesis (M.S.)--Michigan State University. Clinical Laboratory Sciences, 2010","Includes bibliographical references (leaves [41]-45)"]},{"key":"dc:format","label":"Dc Format","values":["vi, 45 pages","application/pdf"]},{"key":"dc:title","label":"Title","values":["A mutation in the gene PTPN22 as an indicator of risk for idiopathic thrombocytopenic purpura"]}]}],"canonical_facts":{"dc:contributor":["Gerlach, John A.","Schwartz, Kenneth","Estry, Douglas"],"dc:creator":["Zamora, Matthew B."],"dc:date":["2010"],"dc:description":["A MUTATION IN THE GENE PTPN22 AS AN INDICATOROF RISK IN IDIOPATHIC THROMBOCYTOPENIC PURPURAByMatthew B. ZamoraImmune-mediated thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet count and antibody mediated platelet destruction. ITP may be due to a failure of T-cell tolerance. Protein tyrosine phosphatase non receptor type 22 (PTPN22) is an important negative regulator of signal transduction from the T cell receptor. A single nucleotide polymorphism 1858C>T in the PTPN22 gene has been associated with various autoimmune disorders with an autoantibody component. We hypothesize that the PTPN22 mutation 1858C>T would be present in a higher proportion of ITP patients due to the humoral immunological component of the disease. We genotyped 45 patients with ITP by a Polymerase Chain Reaction (PCR) based restriction length polymorphism(RFLP) to identify the mutation 1858C>T in the gene PTPN22. Ten patients (22.2%) were heterozygous for the PTPN22 mutation and 2 were homozygous for the mutation (4.4%). The allele frequency of T allele in this ITP group is 15.5%. This compares with a T allele frequency of 8.6% observed in a published population study of 926 controls. Our results indicate that PTPN22 mutation allele is increased in ITP patients when compared to this control group with a P value of 0.02.","Thesis (M.S.)--Michigan State University. Clinical Laboratory Sciences, 2010","Includes bibliographical references (leaves [41]-45)"],"dc:format":["vi, 45 pages","application/pdf"],"dc:identifier":["etd:339","isbn:9781124382517","isbn:1124382518","oclc:931832015","umi:1483626","local:Zamora_grad.msu_0128N_10124","https://doi.org/doi:10.25335/4mwh-8177"],"dc:language":["English"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Autoimmune diseases","T cells--Receptors","Immunopathology","Protein-tyrosine phosphatase"],"dc:title":["A mutation in the gene PTPN22 as an indicator of risk for idiopathic thrombocytopenic purpura"],"dc:type":["Text","Theses"]},"updated_at":"2026-11-18T18:06:03Z"}